PAP
ANAB icon

Persistent Asset Partners’s AnaptysBio ANAB Stock Holding History

Persistent Asset Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Buy
+575
New +$34.9K 0.01% 508
2025
Q4 		– Sell
-754
Closed -$23.1K – 372
2025
Q3 		$23.1K Buy
+754
New +$17.3K 0.02% 202

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Persistent Asset Partners's ANAB Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in AnaptysBio (ANAB) in Q2 2026: 575 shares worth $38.8K. The stake represents 0.01% of the portfolio and ranks #508 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in ANAB as recently as Q3 2025.

Persistent Asset Partners first reported a position in ANAB in Q3 2025 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Persistent Asset Partners held 575 shares of AnaptysBio worth $38.8K as of Q2 2026.
  • AnaptysBio was a new Persistent Asset Partners position in Q2 2026.
  • AnaptysBio made up 0.01% of Persistent Asset Partners's portfolio in Q2 2026, its #508 holding.
  • Persistent Asset Partners first reported a position in AnaptysBio in Q3 2025 and has held it in 2 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.